drugset / Trial / NCT06361485

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

NCT06361485 ↗

Phase 1 Recruiting 100 enrolled R3 Stem Cell R3 Medical Research · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.

Timeline

Start
2024-03-25
Primary completion
2027-03-31
Completion
2028-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Wharton's Jelly Allograft Unknown 10 ml Other

Indications

No indication recorded.